Nutritional supplementation in age-related macular degeneration
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: This review assesses the current status of the knowledge of the role of nutrition in age-related macular degeneration - a leading cause of vision loss in the persons with European ancestry. RECENT FINDINGS: We will evaluate the different nutritional factors and both observational and interventional studies used to assess the association of nutrition with age-related macular degeneration. Persons with intermediate risk of age-related macular degeneration or advanced age-related macular degeneration in one eye are recommended to take the formulation proven in the Age-Related Eye Disease Study (AREDS) to be successful in preventing the development of advanced age-related macular degeneration by 25%. The formulation consists of vitamins C, E, beta-carotene and zinc. In addition, observational data suggest that high dietary intake of macular xanthophylls lutein and zeaxanthin are associated with a lower risk of advanced age-related macular degeneration. Similarly, long-chain polyunsaturated fatty acids derived from fish consumption are also associated with a decreased risk of advanced age-related macular degeneration. SUMMARY: Persons with intermediate age-related macular degeneration or advanced age-related macular degeneration (neovascular or central geographic atrophy) in one eye should consider taking the AREDS-type supplements. Further evaluation of nutritional factors, specifically, lutein/zeaxanthin and omega-3 fatty acids will be tested in a multicenter controlled, randomized trial - the Age-Related Eye Disease Study 2 (AREDS2).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Oxidative damage and protection of the RPE
Cai, J., Nelson, K. C., Wu, M., Sternberg, P., & Jones, D. P. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00009-9 · Cited by 628
Hypertension, cardiovascular disease, and age-related macular degeneration
Hyman, L. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.3.351 · Cited by 441
Dietary fat and risk for advanced age-related macular degeneration
Seddon, J. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.8.1191 · Cited by 408
Prospective study of dietary fat and the risk of age-related macular degeneration
Cho, E., Hung, S., Willett, W. C., Spiegelman, D., Rimm, E. B., Seddon, J. M., Colditz, G. A., & Hankinson, S. E. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.209 · Cited by 350
Oral Zinc in Macular Degeneration
Newsome, D. A., Swartz, M., Leone, N. C., Elston, R. C., & Miller, E. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060130202026 · Cited by 349
Cited by
The ozone paradox: Ozone is a strong oxidant as well as a medical drug
Bocci, V., Borrelli, E., Travagli, & Zanardi, I. (2009) · Medicinal Research Reviews · doi:10.1002/med.20150 · Cited by 422
Biotechnological production of lutein and its applications
Fernández-Sevilla, J. M., Acién Fernández, F. G., & Molina Grima, E. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2420-y · Cited by 406
Lutein: More than just a filter for blue light
Kijlstra, A., Tian, Y., Kelly, E. R., & Berendschot, T. T. J. M. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.03.002 · Cited by 349
Schuman, S. G., Koreishi, A. F., Farsiu, S., Jung, S.-H., Izatt, J. A., & Toth, C. A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.006 · Cited by 280
Effects of lutein and zeaxanthin on aspects of eye health
Ma, L., & Lin, X. (2010) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.3785 · Cited by 261
Molino, A., Mehariya, S., Iovine, A., Casella, P., Marino, T., Karatza, D., Chianese, S., & Musmarra, D. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00415 · Cited by 80
Moyad, M. A., Combs, M. A., Vrablic, A. S., Velasquez, J., Turner, B., & Bernal, S. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0106-y · Cited by 15
Metadata
- Authors
- Coleman, H., & Chew, E.
- Venue
- Current Opinion in Ophthalmology
- Published
- 2007-05
- Volume
- 18
- Issue
- 3
- Pages
- 220-223
- ISSN
- 1040-8738 (ISSN-L)
- OpenAlex
- W2014260894
- Cited by
- 81
- References
- 20
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.